Literature DB >> 2888257

Somatostatin suppression of meningioma cell proliferation in vitro.

J Kunert-Radek, H Stepien, A Radek, M Pawlikowski.   

Abstract

Considering the presence of a stereospecific receptor for somatostatin (SST) in human meningioma cells and the possible involvement of this neuropeptide in the growth control of certain meningioma cell lines, the effects of SST on the proliferation of human meningioma cells in vitro was investigated. Tumour tissues for primary cell cultures were obtained surgically from 2 women with histopathological diagnosis of meningothelial meningioma. The incorporation of [3H]-thymidine into meningioma cells DNA was measured as an index of the cells proliferation. It was shown that SST (10(-7)-10(-5) M) significantly inhibited the [3H]-thymidine incorporation. The results have indicated that SST may have an antiproliferative effects on the meningioma tumour cells in vitro.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2888257     DOI: 10.1111/j.1600-0404.1987.tb05474.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

Review 1.  Update on meningiomas.

Authors:  Santosh Saraf; Bridget J McCarthy; J Lee Villano
Journal:  Oncologist       Date:  2011-10-25

2.  Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma.

Authors:  Derek R Johnson; David W Kimmel; Patrick A Burch; Terrence L Cascino; Caterina Giannini; Wenting Wu; Jan C Buckner
Journal:  Neuro Oncol       Date:  2011-05       Impact factor: 12.300

3.  Intraoperative and postoperative gamma detection of somatostatin receptors in bone-invasive en plaque meningiomas.

Authors:  Emmanuel Gay; Jean Philippe Vuillez; Olivier Palombi; Pierre Yves Brard; Pierre Bessou; Jean Guy Passagia
Journal:  Neurosurgery       Date:  2005-07       Impact factor: 4.654

Review 4.  Functional implications of seizure-induced neurogenesis.

Authors:  Helen E Scharfman
Journal:  Adv Exp Med Biol       Date:  2004       Impact factor: 2.622

5.  Development of a meningioma in a patient with acromegaly during octreotide treatment: are there any causal relationships?

Authors:  E De Menis; G Tulipano; S Villa; D Billeci; C Bonfanti; P Pollara; P Pauletto; A Giustina
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

Review 6.  Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas.

Authors:  Chrissa Sioka; Athanassios P Kyritsis
Journal:  J Neurooncol       Date:  2008-11-21       Impact factor: 4.130

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.